DRD2 and triple-negative breast carcinoma: The authors demonstrate that STAT3/IL6 stimulation governed the DRD2-induced stem cell self-renewal in triple-negative breast cancers, while the induction of cell-cycle arrest at G1 and reduction in cell proliferation and viability were reported to be independent of DRD2.